MC
MCRB icon

Mayo Clinic’s Seres Therapeutics MCRB Stock Holding History

Mayo Clinic’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,000
Closed -$857K – 10
2020
Q2 		$857K Hold
9,000
– – 0.82% 7
2020
Q1 		$643K Hold
9,000
– – 1.63% 5
2019
Q4 		$621K Buy
+9,000
New +$667K 0.7% 5

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mayo Clinic's MCRB Position: Q3 2020 in Review

Mayo Clinic sold out of Seres Therapeutics (MCRB) in Q3 2020, closing a stake of 9,000 shares — an estimated $857K sold.

Mayo Clinic first reported a position in MCRB in Q4 2019 and held it in 3 quarters. The position peaked at $857K in Q2 2020. 113 funds tracked by Wall St. Rank hold MCRB as of Q3 2020.

  • Mayo Clinic reported no remaining Seres Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Mayo Clinic sold 9,000 Seres Therapeutics shares in Q3 2020, an estimated $857K.
  • Mayo Clinic first reported a position in Seres Therapeutics in Q4 2019 and held it in 3 quarters.
  • Mayo Clinic's Seres Therapeutics position peaked at $857K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2020.

Based on Mayo Clinic's 13F filing for Q3 2020, filed 12 Nov 2020.